346 related articles for article (PubMed ID: 20457278)
21. Molecular approaches toward pathologic mechanisms in giant cell arteritis and Takayasu's arteritis.
Weyand CM; Goronzy JJ
Curr Opin Rheumatol; 1995 Jan; 7(1):30-6. PubMed ID: 7718419
[TBL] [Abstract][Full Text] [Related]
22. [Pathogenesis of large vessel vasculitis].
Samson M; Bonnotte B
Rev Med Interne; 2016 Apr; 37(4):264-73. PubMed ID: 26620872
[TBL] [Abstract][Full Text] [Related]
23. An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis.
Albano-Aluquin S; Malysz J; Kidacki M; Ratnam M; Olsen NJ
J Vis Exp; 2019 Feb; (144):. PubMed ID: 30799840
[TBL] [Abstract][Full Text] [Related]
24. Cytokine stimulation of T lymphocytes regulates their capacity to induce monocyte production of tumor necrosis factor-alpha, but not interleukin-10: possible relevance to pathophysiology of rheumatoid arthritis.
Sebbag M; Parry SL; Brennan FM; Feldmann M
Eur J Immunol; 1997 Mar; 27(3):624-32. PubMed ID: 9079801
[TBL] [Abstract][Full Text] [Related]
25. Immunoinhibitory checkpoint deficiency in medium and large vessel vasculitis.
Zhang H; Watanabe R; Berry GJ; Vaglio A; Liao YJ; Warrington KJ; Goronzy JJ; Weyand CM
Proc Natl Acad Sci U S A; 2017 Feb; 114(6):E970-E979. PubMed ID: 28115719
[TBL] [Abstract][Full Text] [Related]
26. Giant cell arteritis. Epidemiology, etiology and pathogenesis.
Nordborg C; Nordborg E; Petursdottir V
APMIS; 2000 Nov; 108(11):713-24. PubMed ID: 11211963
[TBL] [Abstract][Full Text] [Related]
27. Pathogenic mechanisms in giant cell arteritis.
Weyand CM; Goronzy JJ
Cleve Clin J Med; 2002; 69 Suppl 2():SII28-32. PubMed ID: 12086261
[TBL] [Abstract][Full Text] [Related]
28. [Pathogenesis of primary large vessel arteritis].
Arnaud L; Haroche J; Duhaut P; Piette JC; Amoura Z
Rev Med Interne; 2009 Jul; 30(7):578-84. PubMed ID: 18804314
[TBL] [Abstract][Full Text] [Related]
29. Giant cell vasculitis is a T cell-dependent disease.
Brack A; Geisler A; Martinez-Taboada VM; Younge BR; Goronzy JJ; Weyand CM
Mol Med; 1997 Aug; 3(8):530-43. PubMed ID: 9307981
[TBL] [Abstract][Full Text] [Related]
30. The inflammatory infiltrate in giant cell arteritis selects against B lymphocytes.
Martinez-Taboada V; Brack A; Hunder GG; Goronzy JJ; Weyand CM
J Rheumatol; 1996 Jun; 23(6):1011-4. PubMed ID: 8782132
[TBL] [Abstract][Full Text] [Related]
31. Formation of new vasa vasorum in vasculitis. Production of angiogenic cytokines by multinucleated giant cells.
Kaiser M; Younge B; Björnsson J; Goronzy JJ; Weyand CM
Am J Pathol; 1999 Sep; 155(3):765-74. PubMed ID: 10487834
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of Takayasu's arteritis: a 2011 update.
Arnaud L; Haroche J; Mathian A; Gorochov G; Amoura Z
Autoimmun Rev; 2011 Nov; 11(1):61-7. PubMed ID: 21855656
[TBL] [Abstract][Full Text] [Related]
33. Giant cell arteritis and polymyalgia rheumatica: role of cytokines in the pathogenesis and implications for treatment.
Martinez-Taboada VM; Alvarez L; RuizSoto M; Marin-Vidalled MJ; Lopez-Hoyos M
Cytokine; 2008 Nov; 44(2):207-20. PubMed ID: 18986814
[TBL] [Abstract][Full Text] [Related]
34. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
35. [Pathogenesis of large vessel vasculitides].
Arnold S; Holl Ulrich K; Lamprecht P
Z Rheumatol; 2020 Aug; 79(6):505-515. PubMed ID: 32430566
[TBL] [Abstract][Full Text] [Related]
36. Elastic-vessel arteritis in interleukin-1 receptor antagonist-deficient mice involves effector Th1 cells and requires interleukin-1 receptor.
Shepherd J; Nicklin MJ
Circulation; 2005 Jun; 111(23):3135-40. PubMed ID: 15939811
[TBL] [Abstract][Full Text] [Related]
37. [Etiopathogenesis of giant cell arteritis].
Casas JM; Acha MV
An Sist Sanit Navar; 2003; 26(1):43-61. PubMed ID: 12759711
[TBL] [Abstract][Full Text] [Related]
38. Dendritic cells co-localize with activated CD4+ T cells in giant cell arteritis.
Wagner AD; Wittkop U; Prahst A; Schmidt WA; Gromnica-Ihle E; Vorpahl K; Hudson AP; Zeidler H
Clin Exp Rheumatol; 2003; 21(2):185-92. PubMed ID: 12747272
[TBL] [Abstract][Full Text] [Related]
39. Cell-type-specific expression of p53 and p21 in giant cell arteritis.
Nordborg C; Aman P; Persson M; Nordborg E
APMIS; 2005 Sep; 113(9):594-9. PubMed ID: 16218934
[TBL] [Abstract][Full Text] [Related]
40. Th17 and Th1 T-cell responses in giant cell arteritis.
Deng J; Younge BR; Olshen RA; Goronzy JJ; Weyand CM
Circulation; 2010 Feb; 121(7):906-15. PubMed ID: 20142449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
